To test if the changes in SSTR2 expression detected by IHC could be confirmed on the transcriptional level, we performed in silico expression analysis utilizing two publicly available GEO datasets of human prostate cancer gene expression arrays (GDS2545 and GDS4109). The gene discussed is SSTR2; the disease is prostate cancer.